Fmoc-4-Trifluoromethyl-D-Phenylalanine

Fmoc-4-Trifluoromethyl-D-Phenylalanine is an Fmoc-protected D-phenylalanine derivative bearing a para-trifluoromethyl substituent on the aromatic ring. The molecule contains an Fmoc carbamate on the alpha-amino group and a free carboxyl functionality suitable for peptide coupling after activation, with the D stereocenter providing defined chiral control in sequence-defined synthesis. The 4-(trifluoromethyl)phenyl side chain introduces strong electron-withdrawing character and increased hydrophobicity, which can influence amide bond formation kinetics, conformational preferences, and downstream physicochemical properties of the resulting peptides or peptidomimetics. The combination of a stable N-protecting group and a fluorinated aromatic handle makes the compound a practical chiral amino acid building block for protected amino acid chemistry and synthetic intermediate preparation.

1. Peptide Synthesis

Fmoc-4-Trifluoromethyl-D-Phenylalanine supports automated and manual solid-phase peptide synthesis where the Fmoc group enables orthogonal N-protection and controlled deprotection cycles. The D-configuration at the alpha-carbon is retained through coupling steps, allowing stereochemically defined incorporation of a fluorinated aromatic residue into peptide backbones. The para-trifluoromethyl side chain can modulate local hydrophobic packing and aromatic interactions in the assembled sequence, which is relevant for generating peptide analogs with altered conformation and stability. The resulting D-amino acid-containing peptides can be used as research-grade building blocks for sequence libraries and as intermediates for further functionalization.

2. Peptidomimetics And SAR

Fmoc-4-Trifluoromethyl-D-Phenylalanine is suitable for peptidomimetic construction and structure-activity relationship studies because the fluorinated para-CF3 substituent provides a tunable handle for electronic and lipophilicity effects. The Fmoc-protected amino acid format supports rapid incorporation into constrained scaffolds where the D stereocenter can help probe stereochemical determinants of binding or recognition. Side-chain fluorination can be leveraged to generate analog series that systematically vary aromatic electronics while maintaining the same backbone residue identity. Downstream derivatives prepared from these sequences, including modified termini or additional side-chain substitutions, can serve as SAR intermediates for medicinal chemistry workflows.

3. Chemical Biology Probes

Fmoc-4-Trifluoromethyl-D-Phenylalanine can be applied in chemical biology research to introduce a fluorinated D-phenylalanine residue into peptide-based probes and labeling handles. The Fmoc carbamate and carboxyl group enable controlled coupling to biomolecular scaffolds, while the CF3-bearing aromatic side chain can improve membrane association and resistance to certain metabolic transformations in probe design contexts. The stereochemical definition of the D-amino acid supports the preparation of stereochemically consistent probe sets for studying molecular recognition and protease tolerance. The fluorinated residue also provides a structural motif that may be used for analytical tracking and comparative studies across probe analogs.

4. Bioconjugation Chemistry

Fmoc-4-Trifluoromethyl-D-Phenylalanine is compatible with bioconjugation strategies that rely on peptide coupling chemistry to attach defined amino acid units to larger biomolecule frameworks. The protected amine allows stepwise assembly of peptide linkers, and subsequent deprotection and coupling can yield conjugation-ready intermediates with a defined D-amino acid stereocenter. The para-trifluoromethyl aromatic group can serve as a hydrophobic anchor within linkers, potentially affecting conjugate solubility and interaction profiles during downstream derivatization. The resulting conjugation intermediates can be used to generate labeled peptides, affinity reagents, or modular linker systems for applied biochemical research.

5. Pharmaceutical Intermediate Preparation

Fmoc-4-Trifluoromethyl-D-Phenylalanine functions as a chiral amino acid intermediate for pharmaceutical manufacturing and fine chemical synthesis routes that require stereodefined fluorinated building blocks. The Fmoc-protected architecture supports scalable peptide fragment assembly, while the D-configuration provides a controlled stereochemical element for producing D-amino acid-containing intermediates used in drug discovery chemistry. The CF3-substituted phenyl side chain can be carried through synthetic sequences to introduce fluorinated motifs into final active pharmaceutical ingredient candidates or advanced intermediates. The compound's protected amino acid form also aligns with process chemistry needs for isolable, transportable intermediates that undergo standard activation and coupling steps in peptide-based manufacturing flows.

6. Analytical Research Standards

Fmoc-4-Trifluoromethyl-D-Phenylalanine is suitable for analytical research and method development where defined fluorinated amino acid residues are required as standards or internal references. The combination of an Fmoc-protected N-terminus and a D-stereocenter enables consistent chromatographic behavior when used to characterize peptide fragments or to calibrate workflows involving fluorinated aromatic motifs. The CF3 group contributes to distinctive mass spectrometric signatures, supporting targeted detection in LC-MS analyses of peptide libraries and degradation products. The compound can therefore serve as a structurally defined reference material that supports amino acid derivatization studies and peptide coupling chemistry verification in applied analytical settings.

1. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs

2. Sex differences in oxidative stress level and antioxidative enzymes expression and activity in obese pre-diabetic elderly rats treated with metformin or liraglutide

3. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists

4. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment

5. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy